10% owner purchased ~$4.6K of SPRB shares in the open market

Traded Oct 6, 2025 · Filed Oct 9, 2025

Why it stands out

A 10% owner of Spruce Biosciences paid $4.6K out of pocket for Spruce Biosciences shares. The Spruce Biosciences shares held grew by 24%.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

10% ownerIndirect holding<$25KHoldings +24%

Classification

open market purchase

Code P — open-market or private purchase

Absolute commitment

~$4,585

Shares × reported transaction price

Size band

<$25K

Ownership change

+24.4%

Purchase shares ÷ estimated pre-transaction holdings, from the filing

Rarity

Not enough history to judge

Confirmed open-market purchases by the same insider in the available history

Cluster activity

No other insider purchases within 30 days

Distinct insiders at the same issuer with confirmed open-market purchases

Timing vs results

53 days after results of Aug 14, 2025, 35 days before results of Nov 10, 2025

Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results

Planned / mechanical clue

None found in footnotes

Only flagged when a footnote says so; never inferred

The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions within the range of $17.55 to $18. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in this footnote.
The amount reported represents the Reporting Persons' pecuniary interest held through an investment in private funds. Each Reporting Person disclaims beneficial ownership in the securities reported on this Form 4 except to the extent of its or his pecuniary interest, if any, therein, and this report shall not be deemed to be an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.